Marker Therapeutics (MRKR) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 6, 2025, to be held virtually with registration required for attendance.

• Shareholders are encouraged to review proxy materials and vote by June 5, 2025, at 11:59 PM ET.

Voting matters and shareholder proposals

• Election of four directors: David Eansor, Steven Elms, Juan Vera, and Katharine Knobil, with board recommendation to vote for all.

• Advisory vote to approve compensation of named executive officers, recommended for approval.

• Ratification of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.

• Other business may be addressed as appropriate during the meeting or any adjournment.

Board of directors and corporate governance

• Board nominees include a mix of current and new candidates, reflecting ongoing governance oversight.